Beta Bionics, Inc.·4

Feb 3, 8:30 PM ET

CARNEY SEAN 4

4 · Beta Bionics, Inc. · Filed Feb 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-31
CARNEY SEAN
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-01-31+55,83755,837 total
    Exercise: $7.51Exp: 2030-05-14Common Stock (55,837 underlying)
  • Award

    Director Stock Option (right to buy)

    2025-01-31+30,45630,456 total
    Exercise: $7.51Exp: 2032-07-26Common Stock (30,456 underlying)
Footnotes (3)
  • [F1]The shares subject to this option shall vest in 36 equal monthly installments measured from February 12, 2020.
  • [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
  • [F3]The shares subject to this option shall vest in 36 equal monthly installments measured from July 27, 2022.

Documents

1 file
  • 4
    form4-02032025_080201.xmlPrimary